CALR and cancer: Finally, such a prophylactic effect was lost when the cancer cells used for vaccination were depleted of CALR or HMGB1, as well as when exposure to 8-MOP plus 4J UVA irradiation was performed in the presence of an ATP-degrading enzyme or a monoclonal antibody blocking type I IFN receptors (Fig. 6).